Compound Profile Scientific & Efficacy Data C 194 H 312 N 54 O 59 S 2 Molecular Formula 4409 g/mol Molecular Weight 159-195 hours (~7-8 days) Half-Life ~100% (subcutaneous) Bioavailability 1415456-99-3 CAS # 171397054 PubChem ID Developed By 2021 Thomas Kruse Novo Nordisk Primary Benefits Exceptional appetite suppression through dual amylin and calcitonin receptor activation, creating powerful and sustained satiety signals Impressive 10-15% weight loss alone, or 20%+ when combined with semaglutide in the CagriSema combination Uniquely designed to complement GLP-1 medications through an independent mechanism, dramatically enhancing results when combined Amino Acid Sequence Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (acylated with C18 diacid via gamma-Glu linker) Dosing How much do I take
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991427-c2c4d692054b4ff6933f01fc6c5be06c.jpg)
Tm hiu v GABA | nh ngha, tc dng, cch tng GABA t nhin Th By, 26/10/2024 Nu nh bn ang ngh n vic s dng GABA dng thc phm b sung
Seek immediate medical attention (A&E or call 999) if you develop: Severe, persistent abdominal pain radiating to the back (potential pancreatitis) Bloody or black, tarry stools Persistent vomiting with inability to keep down fluids Signs of severe dehydration or altered consciousness Symptoms of bowel obstruction (severe bloating, inability to pass gas or stool, severe cramping) For urgent but non-life-threatening concerns outside of GP hours, contact NHS 111 for advice
sale restricted to research-only contexts
To convert tirzepatide milligrams (mg) to units, you must know the concentration of your medication in mg/mL